NO994932L - Blandinger og fremgangsmåter for behandling og diagnose av brystkreft - Google Patents

Blandinger og fremgangsmåter for behandling og diagnose av brystkreft

Info

Publication number
NO994932L
NO994932L NO994932A NO994932A NO994932L NO 994932 L NO994932 L NO 994932L NO 994932 A NO994932 A NO 994932A NO 994932 A NO994932 A NO 994932A NO 994932 L NO994932 L NO 994932L
Authority
NO
Norway
Prior art keywords
breast cancer
methods
mixtures
treating
diagnosing breast
Prior art date
Application number
NO994932A
Other languages
English (en)
Other versions
NO994932D0 (no
Inventor
Tony N Frudakis
John M Smith
Steven G Reed
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/991,789 external-priority patent/US6225054B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO994932D0 publication Critical patent/NO994932D0/no
Publication of NO994932L publication Critical patent/NO994932L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Blandinger og fremgangsmåter for deteksjon og behandling av brystkreft er vedlagt. De tilveiebragte forbindelsene inkluderer nukleotidsekvenser som fortrinnsvis er irirykt i brysttumorvev, så vel som polypeptider som er kodet for av slike nukleotidsekvenser. Vaksiner og farmasøytiske blandinger innbefattende slike forbindelser er også tilveiebragt og kan for eksempel bli anvendt for forebygging og behandling av brystkreft. Polypeptidene kan også bli anvendt for produksjon av antistoffer, som er egnet for diagnostisering og monitorering av progresjonen til en brystkreftpasient.
NO994932A 1997-04-09 1999-10-08 Blandinger og fremgangsmåter for behandling og diagnose av brystkreft NO994932L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83876297A 1997-04-09 1997-04-09
US08/991,789 US6225054B1 (en) 1996-01-11 1997-12-11 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US1998/006939 WO1998045328A2 (en) 1997-04-09 1998-04-09 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (2)

Publication Number Publication Date
NO994932D0 NO994932D0 (no) 1999-10-08
NO994932L true NO994932L (no) 1999-12-07

Family

ID=27126060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994932A NO994932L (no) 1997-04-09 1999-10-08 Blandinger og fremgangsmåter for behandling og diagnose av brystkreft

Country Status (12)

Country Link
EP (3) EP1127893A2 (no)
JP (1) JP4270523B2 (no)
KR (1) KR20010006220A (no)
AU (1) AU6956098A (no)
BR (1) BR9808509A (no)
CA (1) CA2286348A1 (no)
IL (1) IL132287A0 (no)
NO (1) NO994932L (no)
PL (1) PL336349A1 (no)
TR (1) TR199903154T2 (no)
WO (1) WO1998045328A2 (no)
ZA (1) ZA982968B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
KR20020026418A (ko) * 1999-04-09 2002-04-10 길리스 스티브 유방암을 치료 및 진단하기 위한 조성물 및 방법
AU2004218695B2 (en) * 1999-04-09 2008-05-08 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
EP1248800A2 (en) 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1690872A3 (en) * 1999-12-01 2006-08-23 Genentech, Inc. Composition and methods for the diagnosis of tumours
US20020009738A1 (en) * 2000-04-03 2002-01-24 Houghton Raymond L. Methods, compositions and kits for the detection and monitoring of breast cancer
PT2266603E (pt) 2000-10-18 2012-11-02 Glaxosmithkline Biolog Sa Vacinas tumorais
MXPA03006617A (es) * 2001-01-24 2004-12-02 Protein Design Labs Inc Metodos de diagnostico de cancer de pecho, composiciones y metodos de rastreo de moduladores de cancer de pecho.
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DK0444181T3 (da) * 1989-08-04 2002-02-25 Schering Ag C-erbB-2 eksternt domæne: gp75
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
CA2191099A1 (en) * 1994-05-23 1995-11-30 Howard B. Urnovitz Non-hiv antibodies as disease markers
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5981218A (en) * 1995-08-09 1999-11-09 Bristol-Myers Squibb Company Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
AU728777B2 (en) * 1996-01-11 2001-01-18 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer

Also Published As

Publication number Publication date
ZA982968B (en) 1998-10-27
BR9808509A (pt) 2001-09-18
CA2286348A1 (en) 1998-10-15
TR199903154T2 (xx) 2000-08-21
PL336349A1 (en) 2000-06-19
WO1998045328A2 (en) 1998-10-15
EP1964850A3 (en) 2012-06-20
EP0975666A2 (en) 2000-02-02
JP4270523B2 (ja) 2009-06-03
IL132287A0 (en) 2001-03-19
JP2001521384A (ja) 2001-11-06
EP1127893A2 (en) 2001-08-29
EP1964850A2 (en) 2008-09-03
AU6956098A (en) 1998-10-30
WO1998045328A3 (en) 1999-04-22
KR20010006220A (ko) 2001-01-26
NO994932D0 (no) 1999-10-08

Similar Documents

Publication Publication Date Title
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
EP1876241A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
NO20004631D0 (no) Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
WO2003087831A3 (en) Proteins involved in breast cancer
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
DE60039353D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
HUP0203968A2 (hu) Készítmények és eljárások prosztatarák terápiájára és diagnózisára
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2000052165A3 (en) Compositions and methods for breast cancer therapy and diagnosis
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
HK1056692A1 (en) Proteins
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
GB0305422D0 (en) Detection, monitoring and treatment of cancer
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
EP1363929A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF BREAST CANCER
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses
ATE291738T1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
WO2000073338A8 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
WO1999037778A3 (en) Compositions and methods for detecting and treating prostate cancer
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
AR012389A1 (es) Composiciones y metodos para el tratamiento y diagnostico del cancer de seno

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application